Category: Blog
-
Omega Healthcare gets dividend safety rating downgrade from Simply Safe Dividends
The nursing home REIT is suffering from a host of issues related to the pandemic. One of its operators reported it would no longer be able to pay rent due to lack of occupancy and rising labor costs. Vaccine mandates aren’t making things easier either with only about 61% of the nation’s nursing home staff…
-
Microsoft promotes Panos Panay to senior leadership team
Since the era of ex-Windows lead Terry Myerson, Windows itself hasn’t had a seat at the big boy table within Microsoft. However, that has now changed. Chief Product Officer Panos Panay has taken up a new role as an Executive Vice President (via Bloomberg), joining recent appointee Xbox lead Phil Spencer at the senior leadership table,…
-
2nd Qtr GDP revised up
Large corporations continue their accelerated growth throughout the pandemic. Gross domestic product, the official scorecard for the U.S. economy, rose at a revised 6.6% annualized pace in the second quarter, the government said Thursday. Originally the increase was put at 6.5%. The slight increase in GDP reflected somewhat stronger consumer spending and U.S. exports than initially…
-
WSJ columnist Telis Demos on the benefits of a diversified portfolio
The best advice in this video is if you’re going to buy individual stocks yourself you need to buy in industries that won’t react to the same piece of news in the same way.
-
IBM claims its new microprocessor can help detect fraud in real time
Here’s a video explaining the processor. I don’t quite see how this will help detect fraud in real time since fraud detection requires smart software. Current software has trouble detecting fraud and frequently produces false positives that create a hassle for consumers. I guess the proof will be in the pudding. The processor itself looks…
-
Early data promising for Johnson & Johnson booster shot
Johnson & Johnson is reporting those receiving a booster shot after 6 months show a 9 times increase in antibody levels. The data isn’t peer reviewed yet so it’s early days I guess. J&J said researchers found antibody levels increased ninefold among people who received a second dose of its vaccine, compared with one month…